News
- Author:
- Patrice Wendling
Publish date: May 13, 2022
The low-profile stent shares the same platform as the previous-generation Resolute Onyx zotarolimus-eluting stent and features an enhanced delivery...
News
- Author:
- Patrice Wendling
Publish date: May 10, 2022
National registry data show substantial deviation from the treatment protocols used in the pivotal randomized trials in the years following approva...
News
- Author:
- Patrice Wendling
Publish date: May 5, 2022
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.
News
- Author:
- Patrice Wendling
Publish date: May 3, 2022
A national study uncovered abysmal rates of usage for one of the most studied and inexpensive therapies available.
News
- Author:
- Patrice Wendling
Publish date: April 29, 2022
A new position statement from the Society for Cardiovascular Angiography and Interventions suggests best practices for this increasingly widespread...
News
- Author:
- Patrice Wendling
Publish date: April 22, 2022
The relation is relatively modest but strongly argues for increased testing of Lp(a) and adding atrial fibrillation as a secondary outcome to ongoi...
News
- Author:
- Patrice Wendling
Publish date: April 11, 2022
Results from the sham-controlled trial suggest renal denervation may provide an alternative “adjunctive treatment” in the management of hypertensio...
News
- Author:
- Patrice Wendling
Publish date: April 3, 2022
The results add to growing enthusiasm for achieving the ‘holy grail’ of a lipoprotein(a)-specific lowering agent, but whether it will reduce cardio...
News
- Author:
- Patrice Wendling
Publish date: April 2, 2022
The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role f...
News
- Author:
- Patrice Wendling
Publish date: March 28, 2022
“Should we come across further waves of this pandemic, our advice from a medical point of view should be to promote and facilitate exercise.”
News
- Author:
- Patrice Wendling
Publish date: March 25, 2022
A new position statement says the updated VARC-3 document on clinical endpoint definitions provides many important contributions, but “some importa...
News
- Author:
- Patrice Wendling
Publish date: March 23, 2022
Orthostatic hypertension blood pressure assessment provides prognostic information on top of traditional risk factors and ambulatory blood pressure...
News
- Author:
- Patrice Wendling
Publish date: March 23, 2022
The voluntary nationwide recall of the antihypertensive Accuretic and two generics was prompted by unacceptable levels of N-nitroso-quinapril, a li...
News
- Author:
- Patrice Wendling
Publish date: March 23, 2022
A new policy statement offers organizations and individuals strategies to address bias, discrimination, bullying, and harassment – be it from a col...
News
- Author:
- Patrice Wendling
Publish date: March 14, 2022
A new NHANES analysis found no improvement in hypertension control over the past decade and evidence of racial and ethnic disparities in these youn...
